Advocates teamed up at the Utah State Capitol on Wednesday with health professionals, mitigation experts and a woman with a ...
Chavez, MD, discusses how comprehensive genomic profiling may impact the treatment and clinical management of patients with small cell lung cancer.
A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell ...
Karen B. I am now a very lucky lung cancer survivor. This is due to early detection that only required surgery and no additional treatments. Becca P. Over the course of 19 months, extensive small-cell ...
There are two main types of lung cancer: small cell and non-small cell lung cancer (NSCLC). Non-small cell lung cancer, the more common and slow-growing of the two, consists of different subtypes, ...
was granted a breakthrough therapy designation by the U.S. Food and Drug Administration earlier this month for treatment of the same type of lung cancer when other treatments have failed.
These are drugs that target specific parts of cancer cells or nearby cells that help them grow. So far, these drugs have only been found to be useful for some non-small cell lung cancers. For example, ...
Investors gravitate to small-company stocks for a couple of reasons. Some want a dose of small companies in their portfolios to round out their exposure to the large-company stocks that dominate ...
Exposure to microplastics has been linked with lung cancer.Credit ... shards of plastic less than 5 millimetres long. Many are small enough to enter the bloodstream. We breathe in or consume ...
Dec. 19, 2024 – The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC). Sold under the brand name ...
After reviewing 3,000 studies, researchers from UC San Francisco identified daily occurrences that may be fueling infertility, colon cancer ... the colon, small intestine and lung function.
Small-cell lung cancer is one of the most aggressive types of cancer. It represents about 10 to 15 percent of all lung cancer cases in the United States, with roughly 30,000 to 35,000 new cases ...